Fact CheckerSign in

NCT05559359CompletedPhase 3

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

J2T-MC-KGBI/DRM06-AD13: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age with Moderate-to-Severe Atopic Dermatitis

Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Jun 2026

Brief summary (registry, in English)

To evaluate the efficacy of lebrikizumab when used in combination with TCS treatment, compared with placebo, in participants with moderate-to-severe AD

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
89 (actual)
First submitted
14 Mar 2023
Start date
12 Sept 2023
Lead sponsor
Eli Lilly & Co.
NCT number
NCT05559359
EU CT number
2022-501476-25-00

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 89
  • 24 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have been in a similar study with a similar drug or received a forbidden treatment within the last 2 - 8 weeks.
  • Have had previous reaction to the study drug or the ointments or cremes used in this study.
  • Have an addiction to drugs or alcohol.

Other illness

  • Have a severe or current infection that requires strong antibiotics.
  • Have a history of or have a current disease, or type of illness that your doctor believes could affect your safety.

Other

  • Be pregnant or breastfeeding.

Who the study is looking for

  • Have Atopic Dermatitis for at least 6 months if younger than 6 years old or 1 year if older than 6 years.
  • 6 months to 6 years old and weigh over 6 kilograms.
  • 12 to 18 years old and weigh less than 40 kilograms.
  • A parent or legal guardian must be able to sign the consent document and follow to the guidelines of the study.
  • And meet other additional conditions at the time of the first visit.

Age in the registry: - to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (24)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fakultni Nemocnice Brno
Coordinator of this site? Confirm its status
Brno-SeverCzechiaCompleted
Fakultni nemocnice Bulovka
Coordinator of this site? Confirm its status
PragueCzechiaCompleted
Thermalsole und Schwefelbad Bentheim GmbH
Coordinator of this site? Confirm its status
Bad BentheimGermanyCompleted
Rosenpark Research Gmbh
Coordinator of this site? Confirm its status
DarmstadtGermanyCompleted
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
Coordinator of this site? Confirm its status
DresdenGermanyCompleted
Universitaetsklinikum Frankfurt AöR
Coordinator of this site? Confirm its status
Frankfurt Am MainGermanyCompleted
Universitaetsklinikum Muenster AöR
Coordinator of this site? Confirm its status
MuensterGermanyCompleted
Sant Joan De Deu Barcelona Hospital
Coordinator of this site? Confirm its status
Esplugues De LlobregatSpainCompleted
Hospital Universitario de Gran Canaria Dr Negrín
Coordinator of this site? Confirm its status
Las Palmas de Gran CanariaSpainCompleted
Grupo Dermatológico y Estético Pedro Jaén S.A
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario La Paz
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario 12 de Octubre
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Infantil Universitario Nino Jesus
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital de Manises
Coordinator of this site? Confirm its status
ManisesSpainCompleted
University Clinic of Navarra
Coordinator of this site? Confirm its status
PamplonaSpainCompleted
Complexo Hospitalario Universitario de Pontevedra
Coordinator of this site? Confirm its status
PontevedraSpainCompleted
Hospital Universitario Quironsalud Madrid
Coordinator of this site? Confirm its status
Pozuelo de AlarcónSpainCompleted
Centre Hospitalier Universitaire De Nantes
Coordinator of this site? Confirm its status
Nantes Cedex 1FranceCompleted
Hopitaux Drome Nord
Coordinator of this site? Confirm its status
Romans-Sur-IsereFranceCompleted
Centre Hospitalier Universitaire De Toulouse
Coordinator of this site? Confirm its status
Toulouse Cedex 9FranceCompleted
Diamond Clinic Sp. z o.o.
Coordinator of this site? Confirm its status
CracowPolandCompleted
Centrum Badan Klinicznych PI-House sp. z o.o.
Coordinator of this site? Confirm its status
GdanskPolandCompleted
DERMED Centrum Medyczne Sp. z o.o.
Coordinator of this site? Confirm its status
LodzPolandCompleted
Evimed Sp. z o.o.
Coordinator of this site? Confirm its status
WarsawPolandCompleted

This page is information, not medical advice. Discuss any trial with your doctor.